Code availability
The code to reproduce this analysis can be found at (https://github.com/an0435/aspirin_lung_cancer_MR/).
Change history
11 April 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00432-021-03636-0
References
Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512–525
Burgess S, Labrecque JA (2018) Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates. Eur J Epidemiol 33:947–952
Burgess S, Smith GD, Davies NM, Dudbridge F, Gill D, Glymour MM, Hartwig FP, Holmes MV, Minelli C, Relton CL, Theodoratou E (2020) Guidelines for performing Mendelian randomization investigations. Wellcome Open Res 4:186
Burgess S, Thompson SG (2013) Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol 42:1134–1144
Carreras-Torres R, Johansson M, Haycock PC, Wade KH, Relton CL, Martin RM, Davey Smith G, Albanes D, Aldrich MC, Andrew A, Arnold SM, Bickeböller H, Bojesen SE, Brunnström H, Manjer J, Brüske I, Caporaso NE, Chen C, Christiani DC, Christian WJ et al (2017) Obesity, metabolic factors and risk of different histological types of lung cancer: a Mendelian randomization study. PLoS ONE 12:e0177875
Davey Smith G, Davies NM, Dimou N, Egger M, Gallo V, Golub R, Higgins JP, Langenberg C, Loder EW, Richards JB, Richmond R, Skrivankova VW, Swanson S, Timpson NJ, Tybjaerg-Hansen A, VanderWeele TJ, Woolf BA, Yarmolinsky J (2019) STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies. PeerJ. https://peerj.com/preprints/27857/
Elsworth B, Lyon M, Alexander T, Liu Y, Matthews P, Hallett J, Bates P, Palmer T, Haberland V, Davey Smith G, Zheng J, Haycock P, Gaunt TR, Hemani G (2020) The MRC IEU OpenGWAS data infrastructure. bioRxiv. https://doi.org/10.1101/2020.08.10.244293v1
Elsworth B, Mitchell R, Raistrick C, Paternoster L, Hemani G & Gaunt T (2019) MRC IEU UK Biobank GWAS pipeline, version 2, 18/01/2019. https://data.bris.ac.uk/datasets/pnoat8cxo0u52p6ynfaekeigi/MRC IEU UK Biobank GWAS pipeline version 2.pdf. Accessed 16 Nov 2020
Ference BA, Majeed F, Penumetcha R, Flack JM, Brook RD (2015) Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or Both: A 2 × 2 factorial mendelian randomization study. J Am Coll Cardiol 65:1552–1561
Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, Voros S, Giugliano RP, Davey Smith G, Fazio S, Sabatine MS (2016) Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med 375:2144–2153
Gill D, Georgakis MK, Koskeridis F, Jiang L, Feng Q, Wei W-Q, Theodoratou E, Elliott P, Denny JC, Malik R, Evangelou E, Dehghan A, Dichgans M, Tzoulaki I (2019) Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects. Circulation 140:270–279
Global Lipids Genetics Consortium (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45:1274–1283
van der Harst P, Verweij N (2018) Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res 122:433–443
Jiang Y, Su Z, Li C, Wang R, Wen Y, Liang H, He J, Liang W (2020) Association between use of aspirin and risk of lung cancer: results from pooled cohorts and mendelian randomization analyses. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-020-03394-5
Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133–1163
Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, Saleheen D, Kyriakou T, Nelson CP, Hopewell JC, Webb TR, Zeng L, Dehghan A, Alver M, Armasu SM, Auro K, Bjonnes A, Chasman DI, Chen S, Ford I et al (2015) A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 47:1121–1130
Nounu A, Greenhough A, Heesom KJ, Richmond RC, Zheng J, Weinstein SJ, Albanes D, Baron JA, Hopper JL, Figueiredo JC, Newcomb PA, Lindor NM, Casey G, Platz EA, Marchand L Le, Ulrich CM, Li CI, Duijnhoven FJ van, Gsur A, Campbell PT, et al (2020) A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer. https://cebp.aacrjournals.org/content/early/2020/12/12/1055-9965.EPI-20-1176
Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, Pablo-Fernandez E De, Haycock PC, Lewis PA, Foltynie T, Smith GD, International Parkinson Disease Genomics Consortium, Schrag A, Lees AJ, Hardy J, Singleton A, Nalls MA, Pearce N, Lawlor DA, Wood NW (2017) Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study. PLoS Med. 14: e1002314
Prins BP, Kuchenbaecker KB, Bao Y, Smart M, Zabaneh D, Fatemifar G, Luan J, Wareham NJ, Scott RA, Perry JRB, Langenberg C, Benzeval M, Kumari M, Zeggini E (2017) Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal Study reveals novel associations. Sci Rep 7:11008
Qiao Y, Yang T, Gan Y, Li W, Wang C, Gong Y, Lu Z (2018) Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies. BioMed Cent Cancer 18:1–57
Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV (2020) Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. PLOS 17:e1003062
Sedgwick P (2014) Relative risks versus odds ratios. BMJ 348:g1407
UK Biobank—Neale lab. http://www.nealelab.is/uk-biobank/. Accessed 19 Oct 2020
Acknowledgements
The authors thank Dr Philip C. Haycock for his feedback considering the manuscript.
Funding
This work was funded by Cancer Research UK (C18281/A19169) and the Medical Research Council Integrative Epidemiology Unit, which is supported by the Medical Research Council and the University of Bristol [MC_UU_00011/1 and MC_UU_00011/4].
Author information
Authors and Affiliations
Contributions
AN provided the initial concept, performed the statistical analysis and drafted the manuscript. VW helped with reviewing and editing the manuscript. RCR helped with supervising as well as reviewing and editing the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Availability of data and material
Data are freely available on the online platform for MR Base (http://app.mrbase.org/) as well as through the TwoSampleMR R package (github.com/MRCIEU/TwoSampleMR).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised due to open access cancellation.
Rights and permissions
About this article
Cite this article
Nounu, A., Walker, V. & Richmond, R.C. Letter regarding, “Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses”. J Cancer Res Clin Oncol 147, 2171–2173 (2021). https://doi.org/10.1007/s00432-020-03508-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-020-03508-z